Total Payments
$878.41
2024 Payments
$340.25
Companies
17
Transactions
53
Medicare Patients
959
Medicare Billing
$73,687
Payment Breakdown by Category
Food & Beverage$878.41 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $878.41 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $357.29 | 23 | $0 (2024) |
| Lilly USA, LLC | $121.86 | 8 | $0 (2024) |
| Abbott Laboratories | $46.36 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $42.42 | 2 | $0 (2023) |
| Edwards Lifesciences Corporation | $36.36 | 1 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $35.34 | 2 | $0 (2024) |
| Exact Sciences Corporation | $33.29 | 2 | $0 (2023) |
| Novo Nordisk Inc | $33.18 | 2 | $0 (2023) |
| PFIZER INC. | $30.02 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $27.63 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $340.25 | 22 | ABBVIE INC. ($193.06) |
| 2023 | $321.72 | 18 | ABBVIE INC. ($108.58) |
| 2022 | $122.41 | 7 | ABBVIE INC. ($37.81) |
| 2021 | $66.00 | 4 | Lilly USA, LLC ($27.21) |
| 2019 | $28.03 | 2 | GlaxoSmithKline, LLC. ($15.86) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PAIN | ||||||
| 02/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 01/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $36.36 | General |
| 12/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Gastroenterology | ||||||
| 11/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Oncology | ||||||
| 11/14/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 278 | 310 | $56,338 | $23,330 |
| 2022 | 8 | 268 | 315 | $44,822 | $21,337 |
| 2021 | 7 | 230 | 276 | $40,270 | $19,040 |
| 2020 | 7 | 183 | 197 | $25,744 | $9,980 |
Total Patients
959
Total Services
1,098
Medicare Billing
$73,687
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 78 | 78 | $23,556 | $9,823 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 88 | $17,185 | $6,555 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 45 | $7,383 | $2,324 | 31.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,388 | $1,711 | 50.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $2,300 | $1,579 | 68.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $1,588 | $765.70 | 48.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $418.00 | $323.95 | 77.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 26 | $520.00 | $247.52 | 47.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 71 | 71 | $21,442 | $9,133 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 86 | $13,588 | $6,500 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 44 | $5,280 | $2,576 | 48.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $2,090 | $1,505 | 72.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $1,064 | $792.70 | 74.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 16 | 16 | $608.00 | $456.41 | 75.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 16 | 34 | $680.00 | $326.19 | 48.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 14 | $70.00 | $48.04 | 68.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 62 | 62 | $18,724 | $8,136 | 43.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 78 | $12,324 | $5,899 | 47.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 40 | $4,800 | $2,483 | 51.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 24 | 24 | $2,280 | $1,562 | 68.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 28 | 28 | $1,064 | $459.08 | 43.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 17 | 33 | $660.00 | $320.43 | 48.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 11 | 11 | $418.00 | $179.80 | 43.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 31 | 31 | $9,012 | $3,502 | 38.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 48 | 59 | $9,322 | $3,173 | 34.0% |
About Dr. Amy Kriger, DO
Dr. Amy Kriger, DO is a Family Medicine healthcare provider based in Homer City, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2015. The National Provider Identifier (NPI) number assigned to this provider is 1982083069.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Kriger, DO has received a total of $878.41 in payments from pharmaceutical and medical device companies, with $340.25 received in 2024. These payments were reported across 53 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($878.41).
As a Medicare-enrolled provider, Kriger has provided services to 959 Medicare beneficiaries, totaling 1,098 services with total Medicare billing of $73,687. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Homer City, PA
- Active Since 05/22/2015
- Last Updated 04/13/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982083069
Products in Payments
- UBRELVY (Drug) $152.26
- QULIPTA (Drug) $98.13
- VRAYLAR (Drug) $88.52
- MOUNJARO (Drug) $66.96
- TRULICITY (Drug) $54.90
- VOQUEZNA (Drug) $35.34
- NURTEC ODT (Drug) $34.12
- Cologuard Collection Kit (Device) $33.29
- FREESTYLE LIBRE 3 (Device) $23.71
- VAXELIS (Biological) $23.64
- PROCLAIM (Device) $22.65
- AJOVY (Biological) $20.95
- GARDASIL 9 (Biological) $18.78
- SYNTHROID (Drug) $18.38
- Ozempic (Drug) $16.79
- Rybelsus (Drug) $16.39
- TRADJENTA (Drug) $16.24
- ANORO (Drug) $15.86
- PAXLOVID (Drug) $15.83
- Otezla (Drug) $15.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.